WOODCLIFF LAKE, N.J., April 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) ("Par") today announced it has entered into a settlement agreement with Reliant Pharmaceuticals, Inc.

Alkermes, Inc. (NASDAQ: ALKS) today announced that it will receive up to $174 million in cash in connection with the acquisition of Reliant Pharmaceuticals, Inc. (Reliant) by GlaxoSmithKline (GSK), announced earlier today.

LONDON, PHILADELPHIA and LIBERTY CORNER, N.J., Nov. 21 /PRNewswire- FirstCall/ -- GlaxoSmithKline and Reliant Pharmaceuticals Inc. announced today that they had reached an agreement under which Reliant will be acquired by GSK for $1.65 billion (800 million pounds Sterling) in cash.

LIBERTY CORNER, N.J., Jan. 30 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced that Bradley T.

LIBERTY CORNER, N.J., Jan. 3 /PRNewswire/ -- Reliant Pharmaceuticals, Inc. today announced that Ernest Mario, Ph.D., the company's Chairman and Chief Executive Officer, will present at the 25th Annual JPMorgan Healthcare Conference on Monday, January 8 at 2:00 PM Pacific.